Clinical trial Recruiting at 1 site Interventional Ages 18 and up

LGBTQ+-affirming virtual therapy combining CBT and expressive writing for trauma and alcohol use

Official title: Developing a Telehealth Intervention for Alcohol and Trauma Among LGBTQ+ People

Run by University of Rhode Island · NCT07217795 · Data updated 2026-11-12

This study will test a brief, virtual LGBTQ+-affirming therapy that combines cognitive behavioral techniques and expressive writing to see if it helps LGBTQ+ adults with PTSD and problematic alcohol use.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorUniversity of Rhode Island
Academic / other
Locations1 site (Providence, Rhode Island)
StatusRecruiting
StartedNovember 30, 2025
Main results expectedNovember 2026
Study endsSeptember 2028
Registry record updatedDecember 9, 2025
Trial IDNCT07217795 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are LGBTQ+ adults who have experienced trauma and currently use alcohol but do not need medical detoxification and do not have active psychosis or uncontrolled mania.

Probably not a fit

People who require alcohol detoxification, have active psychosis or severe mania, or who are currently in intensive alcohol or trauma-focused treatment are unlikely to benefit from this brief intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project has two parts: first, researchers will gather input from LGBTQ+ community members to adapt the program so it is inclusive and relevant; second, eligible participants may be offered the adapted brief therapy delivered virtually by LGBTQ+-affirming clinicians. The intervention pairs cognitive behavioral therapy strategies with expressive writing exercises and will be compared to a wait-list control. Participants will be screened for safety (for example, severe withdrawal risk, active psychosis, or mania are exclusionary) and outcomes will include PTSD symptoms, alcohol use, and self-efficacy measures. The program is delivered remotely through the University of Rhode Island team.

Why it matters

Potential benefit: If successful, the program could reduce PTSD symptoms and risky drinking while improving coping and self-efficacy in LGBTQ+ people who have experienced trauma.

How similar studies have gone: Cognitive behavioral therapy and expressive writing have shown benefits for PTSD and alcohol problems in prior work, but brief, virtual adaptations specifically tailored for LGBTQ+ people are relatively novel and less well tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Aim 1: Sexual Minority Women and Transgender and Gender Diverse Individuals -Not meeting inclusion criteria

Aim 1: Providers

-Not meeting inclusion criteria

Aim 2: Sexual Minority Women and Transgender and Gender Diverse Individuals

* Not meeting inclusion criteria OR any of the following:
* Reporting current mental health treatment ≥1 day/month
* Receiving Cognitive Behavioral Therapy (CBT) in the past 3 months (note: participants are not ineligible if they seek concomitant care after enrollment)
* Reporting current alcohol or drug use disorder treatment, except mutual self-help (e.g., Alcoholics Anonymous) or current PTSD/trauma-focused treatment
* Need for alcohol detoxification, defined as score ≥15 on the adapted self-report Clinical Institute Withdrawal Assessment for Alcohol - Revised (CIWA-Ar)
* Active psychosis, defined as score ≥1 on the psychosis subscale of the Behavior and Symptom Identification Scale - Revised (BASIS-R)
* Active mania, defined as score ≥6 on the Altman Self-Rating Mania Scale (ASRM)
* Active suicidality, defined as score ≥22 on the Suicidal Ideation Attributes Scale (SIDAS)
* Currently legally mandated to attend treatment

Where it's running

  • University of Rhode Island
    Providence, Rhode Island, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Hyperbaric Oxygen Therapy for Veterans With TBI and PCS

    This study tests whether 40 HBOT sessions can change blood biomarkers in veterans with traumatic brain injury and persistent symptoms, and whether PTSD affects those biomarker changes.

    Recruiting Phase 2 Summit Hyperbarics and Wellness · Boise, Idaho · NCT07849465

  • Imaging Mitochondrial Complex-I and Brain Metabolism in Alcohol Use Disorder

    This study tests whether PET imaging with [18F]BCPP-EF and [18F]FDG can reveal differences in brain energy use between adults with alcohol use disorder and healthy controls, and whether these measures relate to relapse risk.

    Recruiting Early Phase 1 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07825818

  • Endurance exercise to see if it lowers alcohol use in adults with AUD and ALD

    A 12-week home-based cycling program added to standard care is tested to see if it reduces alcohol use and cravings in adults with alcohol use disorder and alcohol-related liver disease.

    Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT07824089

  • Internet-delivered ACT for youth with PTSD and chronic pain

    A small pilot study will test a web-based Acceptance and Commitment Therapy program for teens and young adults with PTSD and chronic pain to see if it helps with symptoms and functioning.

    Recruiting Skane University Hospital · Lund · NCT07813728

  • Do beverage cues drive craving in adults with AUD

    In adults with alcohol use disorder, this study tests whether different non-alcoholic beverage cues can trigger cravings differently when people see and smell them without drinking.

    Recruiting University of Texas Southwestern Medical Center · Dallas, Texas · NCT07788716

  • Semaglutide for Alcohol Use Disorder and Obesity: Testing 1.0 mg and 2.0 mg vs Placebo

    We’re testing two doses of semaglutide to see if they reduce alcohol craving and use in adults with alcohol use disorder and obesity compared with placebo.

    Recruiting at 2 sites Phase 1 Yale University · New Haven, Connecticut and 1 other locations · NCT07772960

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.